Lung cancer
Conditions
Interventions
Gold Standard:Pathological examination
Index test:Patient's age, gender, height, weight, clinical diagnosis, blood routine, staging, number of lymph node metastases in surgical patients, and CIRP expression level
Sponsors
The First Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.1 Selection criteria 1.1.1 Lung cancer group 1) Confirmed lung cancer patients; 2) Volunteers who have not been infected recently and have white blood cells within the range of 4-10 × 109/L detected by blood routine tests; 3) The age range of the subjects is 18-75 years old; 4) Voluntarily participate in the study and sign an informed consent form, with the ability to comply with the research protocol. 1.1.2 Health group 1) Physically healthy group or benign lung patients; 2) Volunteers who have not recently been infected and have white blood cells within the range of 4-10 × 109/L in their blood routine test; 3) The age range of the subjects is 18-75 years old; 4) Voluntarily participate in the study and sign an informed consent form, with the ability to comply with the research protocol.
Exclusion criteria
Exclusion criteria: 1.2.1 Lung cancer group 1) Patients with a history of cancer; 2) Patients with chronic inflammation; 3) Has taken interfering drugs during blood collection (such as antipyretics, analgesics, and anti infective drugs that are prohibited for white blood cell count; drugs that are prohibited for red blood cell count include methotrexate, phenytoin sodium, etc.; drugs that are prohibited for eosinophil count include adrenal steroids and ACTH; aspirin has an inhibitory effect on platelet aggregation); 4) Diseases such as heart, liver, kidney, and connective tissue. The healthy group in 1.2.2 is the same as the lung cancer group in 1.2.1.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lung cancer;the level of CIRP;Number of lymph node metastases in surgical patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| sensitivity;specificity; | — |
Countries
China
Contacts
Public ContactHaidong Wang
The First Affiliated Hospital of the Army Medical University
Outcome results
None listed